To the best of our knowledge, we are the first to knockdown MMP-2/MMP-9 in RB cell in vitro stably by shRNA gene silencing technique, which was different from the study of Webb et al. in 2017 [13]. This evidence concerns the gene MMP9 and retinoblastoma.